This study is in progress, not accepting new patients
A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard of Care
Summary
- Eligibility
- for people ages 1 year and up (full criteria)
- Location
- at UCLA UCSF
- Dates
- study startedstudy ends around
- Principal Investigator
- by Mala Setty (ucsf)Priya Kathpalia (ucsf)
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientists at University of California Health
- Mala Setty (ucsf)
Professor, Pediatrics, School of Medicine. Authored (or co-authored) 16 research publications - Priya Kathpalia (ucsf)
Dr. Priya Kathpalia is a gastroenterologist and the Medical Director of Motility at UCSF Health, specializing in the diagnosis and management of esophageal motility disorders, gastroesophageal reflux disease (GERD), eosinophilic esophagitis, and other complex foregut conditions.
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Regeneron Pharmaceuticals
- ID
- NCT06693531
- Study Type
- Observational [Patient Registry]
- Participants
- About 368 people participating
- Last Updated